rolls_royce the sales of Rolls-Royce leap of 20%
Whereas all the manufacturers of luxury did not officialize yet the integrality of their figures for the year 2008, Rolls-Royce indicates its first results and one can say that the year 2008 was very good for the subsidiary company of BMW.

With lorazepam contraindications sold units, Rolls-Royce posts a proud progression of 20%.

By analyzing the figures by geographical sector, one notes that the marketing of the Rolls-Royce limousines exploded in Northern Europe with a rise of 95%. lorazepam contraindications same time, the sales in the lorazepam contraindications East climbed of 48%.

North America constituted the most important outlet for trade with 38% of the sold units.

Rolls Royce Phantom